Lanreotide Acetate
NDC 69097-880, lanreotide acetate, injection, from Cipla USA Inc..
- Product NDC
- 69097-880
- Status
- Listed
- Labeler
- Cipla USA Inc.
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA215395
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-880 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LANREOTIDE ACETATE60 mg/.2mL
Pharmacologic classes
Somatostatin Analog [EPC]; Somatostatin Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-880-67 | 69097088067 | 1 SYRINGE in 1 CARTON (69097-880-67) / .2 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/11da176a-99bc-4ada-8b3f-6bd2b37a6313
Use it
Look up 69097-880 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-880 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-880. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.